Promisia gets R&D funding from Callaghan for canine dietary supplement

Promisia gets R&D funding from Callaghan for canine dietary supplement
Rebecca Howard
By Rebecca Howard April 27 (BusinessDesk) - Promisia Integrative, which makes a dietary supplement for sore joints, will receive funds from Callaghan Innovation for research and development for a new supplement for canines. Its shares surged 19 percent to 3.8 cents. According to the company, the grant will reimburse 40 percent of the total cost to undertake a two-year approved programme of research and development.  Its flagship product is Arthrem, a dietary supplement for joint support for humans. The proprietary extract made from the...